Psoriasis: a possible risk factor for development of coronary artery calcification

Ralf J. Ludwig(University of Lübeck), Wolf‐Henning Boehncke(University Hospital of Geneva), Roland Kaufmann(Robert Koch Institute), Thomas M. Zollner(Bayer (Germany)), Falk Ochsendorf(University Hospital Frankfurt), Diamant Thaçi(University of Lübeck), A Rostock(Goethe University Frankfurt), C. Herzog(Goethe University Frankfurt), Thomas J. Vogl(Goethe University Frankfurt)

British Journal of Dermatology

October 18, 2006

10.1111/j.1365-2133.2006.07562.x

Cited by 376

Related Papers

Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines

|European Journal of Cancer|2019|589

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

|The Lancet|2015|566

Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition

|BMC Cancer|2012|561

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

|The Lancet|2021|538

European Evidence‐based (S3) Guidelines for the Treatment of Acne

|Journal of the European Academy of Dermatology and Venereology|2012|422